Mr. David Lawrence, M.B.A., is Chief Financial Officer of Acorda Therapeutics, Inc., since January 2005. He previously served as Vice President, Finance from January 2001 through 2004, and Director, Finance from 1999 to 2001. From 1991 to 1999, Mr. Lawrence held several positions for TelAir Communications, Inc. including Vice President and Controller. Prior to TelAir, he held the financial management positions of Controller and Finance Manager for Southwestern Bell and Metromedia Telecommunications, respectively. Mr. Lawrence received his undergraduate degree in Accounting from Roger Williams College, and an M.B.A in Finance from Iona College. Mr. Lawrence is a founding member and currently serves on the board of directors and as Treasurer of The Brian Ahearn Children?s Fund.
Age: 52 CFO Since 2005
The company has return on total asset (ROA) of 1.96 % which means that it generated profit of $1.96 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 47.8 % meaning that it created $47.8 on every $100 dollars invested by stockholders.
The company currently holds 4.28 M in liabilities with Debt to Equity (D/E) ratio of 0.01 which may suggest the company is not taking enough advantage from borrowing. Acorda Therapeutics Inc has Current Ratio of 3.96 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummaryAcorda Therapeutics, Inc., a commercialstage biopharmaceutical company, engages in the identification, development, and commercialization of therapies for multiple sclerosis , spinal cord injury , and other central nervous system disorders primarily in the United States. Acorda Therapeutics Inc [ACOR] is traded on NASDAQ in USA. It is located in Acorda Therapeutics, Inc.Ardsley, NY and employs 378 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| ACOR Nasdaq
Acorda Therapeutics Inc
Acorda Therapeutics Inc has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Acorda price boundaries
Promote Acorda and David Lawrence